Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan
· Delayed Price · Currency is JPY 2,349.00
+50.00 (2.17%)
Feb 19, 2025, 3:30 PM JST
Rohto Pharmaceutical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 295,572 | 270,840 | 238,664 | 199,646 | 181,287 | 188,327 | Upgrade
|
| Revenue Growth (YoY) | 12.14% | 13.48% | 19.54% | 10.13% | -3.74% | 2.58% | Upgrade
|
| Cost of Revenue | 126,709 | 113,554 | 101,243 | 83,157 | 74,560 | 74,087 | Upgrade
|
| Gross Profit | 168,863 | 157,286 | 137,421 | 116,489 | 106,727 | 114,240 | Upgrade
|
| Selling, General & Admin | 115,946 | 101,377 | 89,859 | 76,435 | 73,933 | 82,531 | Upgrade
|
| Research & Development | 13,390 | 13,390 | 11,065 | 8,740 | 7,903 | 7,050 | Upgrade
|
| Operating Expenses | 132,040 | 117,119 | 103,883 | 88,297 | 84,860 | 91,358 | Upgrade
|
| Operating Income | 36,823 | 40,167 | 33,538 | 28,192 | 21,867 | 22,882 | Upgrade
|
| Interest Expense | -580 | -196 | -247 | -248 | -145 | -125 | Upgrade
|
| Interest & Investment Income | 1,971 | 2,009 | 2,285 | 751 | 1,532 | 1,203 | Upgrade
|
| Earnings From Equity Investments | -246 | -289 | 56 | 143 | 396 | -1,192 | Upgrade
|
| Currency Exchange Gain (Loss) | 392 | 447 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 210 | 294 | -64 | 245 | 260 | -33 | Upgrade
|
| EBT Excluding Unusual Items | 38,570 | 42,432 | 35,568 | 29,083 | 23,910 | 22,735 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,374 | -798 | -160 | -368 | 787 | 425 | Upgrade
|
| Gain (Loss) on Sale of Assets | -67 | - | - | - | - | 153 | Upgrade
|
| Asset Writedown | -134 | -348 | -1,338 | -892 | -1,691 | -1,691 | Upgrade
|
| Other Unusual Items | - | 230 | 219 | 129 | - | 109 | Upgrade
|
| Pretax Income | 39,743 | 41,516 | 34,289 | 27,952 | 23,006 | 21,731 | Upgrade
|
| Income Tax Expense | 10,267 | 10,123 | 7,860 | 6,803 | 6,236 | 6,448 | Upgrade
|
| Earnings From Continuing Operations | 29,476 | 31,393 | 26,429 | 21,149 | 16,770 | 15,283 | Upgrade
|
| Minority Interest in Earnings | 109 | -457 | -52 | -131 | -27 | 127 | Upgrade
|
| Net Income | 29,585 | 30,936 | 26,377 | 21,018 | 16,743 | 15,410 | Upgrade
|
| Net Income to Common | 29,585 | 30,936 | 26,377 | 21,018 | 16,743 | 15,410 | Upgrade
|
| Net Income Growth | -4.25% | 17.28% | 25.50% | 25.53% | 8.65% | 57.26% | Upgrade
|
| Shares Outstanding (Basic) | 228 | 228 | 228 | 228 | 228 | 228 | Upgrade
|
| Shares Outstanding (Diluted) | 229 | 229 | 229 | 229 | 229 | 229 | Upgrade
|
| Shares Change (YoY) | 0.00% | - | -0.00% | - | 0.01% | -0.00% | Upgrade
|
| EPS (Basic) | 129.68 | 135.60 | 115.62 | 92.13 | 73.39 | 67.56 | Upgrade
|
| EPS (Diluted) | 129.30 | 135.21 | 115.29 | 91.86 | 73.18 | 67.36 | Upgrade
|
| EPS Growth | -4.26% | 17.28% | 25.50% | 25.53% | 8.65% | 57.26% | Upgrade
|
| Free Cash Flow | - | 26,266 | 22,451 | 16,983 | 11,287 | 13,454 | Upgrade
|
| Free Cash Flow Per Share | - | 114.80 | 98.13 | 74.23 | 49.33 | 58.81 | Upgrade
|
| Dividend Per Share | 31.000 | 27.000 | 22.000 | 18.000 | 14.000 | 13.000 | Upgrade
|
| Dividend Growth | 29.17% | 22.73% | 22.22% | 28.57% | 7.69% | 13.04% | Upgrade
|
| Gross Margin | 57.13% | 58.07% | 57.58% | 58.35% | 58.87% | 60.66% | Upgrade
|
| Operating Margin | 12.46% | 14.83% | 14.05% | 14.12% | 12.06% | 12.15% | Upgrade
|
| Profit Margin | 10.01% | 11.42% | 11.05% | 10.53% | 9.24% | 8.18% | Upgrade
|
| Free Cash Flow Margin | - | 9.70% | 9.41% | 8.51% | 6.23% | 7.14% | Upgrade
|
| EBITDA | 46,175 | 48,854 | 41,339 | 35,865 | 28,615 | 29,819 | Upgrade
|
| EBITDA Margin | 15.62% | 18.04% | 17.32% | 17.96% | 15.78% | 15.83% | Upgrade
|
| D&A For EBITDA | 9,352 | 8,687 | 7,801 | 7,673 | 6,748 | 6,937 | Upgrade
|
| EBIT | 36,823 | 40,167 | 33,538 | 28,192 | 21,867 | 22,882 | Upgrade
|
| EBIT Margin | 12.46% | 14.83% | 14.05% | 14.12% | 12.06% | 12.15% | Upgrade
|
| Effective Tax Rate | 25.83% | 24.38% | 22.92% | 24.34% | 27.11% | 29.67% | Upgrade
|
| Advertising Expenses | - | 54,219 | 46,467 | 38,114 | 40,525 | 47,927 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.